Home » Raptor Pharma Cystinosis Drug Meets Late-Stage Trial Goal
Raptor Pharma Cystinosis Drug Meets Late-Stage Trial Goal
Raptor Pharmaceutical announced its late-stage clinical trial of its investigational drug delayed release Cysteamine, for the treatment of nephropathic cystinosis, met the primary endpoint.
RTTNews
RTTNews
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May